Biotie: Notification according to Chapter 9, Section 10 of the Finnish Securities Market Act
ET | Source:Biotie Therapies
BIOTIE THERAPIES CORP. STOCK EXCHANGE RELEASE 14 November 2013 at 3.30 pm.
Notification according to Chapter 9, Section 10 of the Finnish Securities Market
Biotie Therapies Corp. ("Company" or "Biotie") has gained knowledge of a
notification regarding changes in number of votes in accordance with Chapter 9,
Section 5 of the Finnish Securities Markets Act, described below.
The notification received by the Company concerns the changes in holdings of the
Company's shares by Novo A/S as a result of the transactions carried out on 13
November 2013. As a result of these transactions, the aggregate holding of Novo
A/S has decreased below 5 per cent of the total number of shares and votes of
The change in holdings in accordance with Chapter 9, Section 5 of the Finnish
Securities Markets Act of which the Company has gained knowledge of is described
Name Number of shares Number of shares (%) of shares (%) of voting
and voting rights and voting rights after rights after
Novo A/S 26,141,552 17,441,554 3.85% 3.91%
The registered number of shares in Biotie Therapies Corp. is 452,710,738. Of
these shares 6,509,351 are held by the Company and the number of outstanding
shares and voting rights attached to the shares amounts thus to 446,201,387.
Turku, 14 November 2013
Biotie Therapies Corp.
President and CEO
For further information please contact:
Tel: +358 2 2748 900
Investor Relations Manager
Tel: +358 2 2748 911
NASDAQ OMX Helsinki Ltd
GlobeNewswire, a Nasdaq company, is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
2321 Rosecrans Avenue.
El Segundo, CA 90245 Phone: (800) 307-6627 Fax: (800) 307-3567
25 Basinghall Street,
London EC2V 5HA
UK Phone: +1 866-465-8454